All lobbying filings

MILLER STRATEGIES, LLC

Lobbying for AMGEN, INC. · biopharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · $60,000.00 income · posted Oct 20, 2025

Official filing document

Bills named in this filing 1

HR 3517
Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Lobbying activity 3

Health Issues

Healthcare policy issues as they relate to the pharmaceutical industry including drug pricing and biosimilars

Medicare/Medicaid

Issues related to drug pricing, biosimilars, Medicare Part D and Medicare Part B; H.R. 3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021

Immigration

Issues related to visas

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.